基本信息
浏览量:3
职业迁徙
个人简介
Professor Seymour is a member of several national and international scientific committees including Cancer Australia Advisory Groups, the Scientific Advisory Committee for the International Workshop on CLL, International Conference on Malignant Lymphoma, Medical Advisory Board of the Lymphoma Coalition, and the Board of Directors of the International Extranodal Lymphoma Study Group. He previously served as Associate Director of Clinical Research at the Peter MacCallum Cancer Centre and Chairman of the ALLG clinical trials group.
Professor Seymour has authored 20 book chapters, more than 600 peer reviewed publications (with more than 50,000 literature citations and h-index of 97), and over 900 conference abstracts. Actively involved in a broad range of collaborative research, Professor Seymour has been the principal investigator on more than 90 clinical trials predominantly in the domains of early drug development and the indolent lymphoproliferative disorders, especially CLL and follicular lymphoma.
Professor Seymour has authored 20 book chapters, more than 600 peer reviewed publications (with more than 50,000 literature citations and h-index of 97), and over 900 conference abstracts. Actively involved in a broad range of collaborative research, Professor Seymour has been the principal investigator on more than 90 clinical trials predominantly in the domains of early drug development and the indolent lymphoproliferative disorders, especially CLL and follicular lymphoma.
研究兴趣
论文共 900 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
BLOOD CANCER JOURNALno. 1 (2024)
Blood Cancer Journalno. 1 (2024): 1-12
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S100-S101
引用0浏览0引用
0
0
HemaSphereno. 7 (2023): e919-e919
Ing S Tiong,William S Stevenson,Meaghan Wall, Yan Zhuang Yap,John F Seymour,Melita Kenealy,Piers Blombery,
eJHaemno. 4 (2023): 1212-1215
Bloodno. 8 (2023): 687-699
crossref(2023)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn